Sign Up to like & get
recommendations!
1
Published in 2018 at "Bulletin du cancer"
DOI: 10.1016/j.bulcan.2018.10.002
Abstract: Donor lymphocyte infusion (DLI) can be proposed to treat or prevent the relapse of malignant hemopathies following allogeneic stem cell transplantation. The efficiency has been mainly reported in the treatment of CML and low-grade lymphomas…
read more here.
Keywords:
infusions dli;
donor lymphocyte;
transplantation;
lymphocyte infusions ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Leukemia research"
DOI: 10.1016/j.leukres.2018.07.005
Abstract: The combination of 5-azacytidine (AZA) with donor lymphocyte infusions (DLIs) can induce remissions in patients with relapsed myeloid malignancies after allo-HCT. As decitabine (DAC) is known to be effective also in AML/MDS with leukocytosis, we…
read more here.
Keywords:
combination;
allo hct;
lymphocyte infusions;
donor lymphocyte ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2020 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2020.572918
Abstract: We conducted a retrospective multicenter study including pediatric and adult patients with acute leukemia (AL) who received donor lymphocyte infusions (DLIs) after allogeneic hematopoietic stem cell transplantation (HCT) between January 1, 2010 and December 31,…
read more here.
Keywords:
dli;
lymphocyte infusions;
stem cell;
acute leukemia ... See more keywords